FIFTH THIRD BANCORP - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.8%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$12,000
+200.0%
347
+40.5%
0.00%
Q2 2020$4,0000.0%2470.0%0.00%
Q1 2020$4,000
-50.0%
2470.0%0.00%
Q4 2019$8,000
-27.3%
247
-54.0%
0.00%
Q3 2019$11,000
+120.0%
537
+117.4%
0.00%
Q2 2019$5,000
-16.7%
247
-0.8%
0.00%
Q1 2019$6,0000.0%2490.0%0.00%
Q4 2018$6,0002490.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders